TNSN00085A1 - Composition pharmaceutique comprenant de l'amlodipine et de l'atorvastatine ou un de ses metabolites - Google Patents

Composition pharmaceutique comprenant de l'amlodipine et de l'atorvastatine ou un de ses metabolites

Info

Publication number
TNSN00085A1
TNSN00085A1 TNTNSN00085A TNSN00085A TNSN00085A1 TN SN00085 A1 TNSN00085 A1 TN SN00085A1 TN TNSN00085 A TNTNSN00085 A TN TNSN00085A TN SN00085 A TNSN00085 A TN SN00085A TN SN00085 A1 TNSN00085 A1 TN SN00085A1
Authority
TN
Tunisia
Prior art keywords
atorvastatin
amlodipine
pharmaceutical composition
metabolites
composition
Prior art date
Application number
TNTNSN00085A
Other languages
English (en)
Inventor
R Preston Mason
Original Assignee
R Preston Mason
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27494873&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TNSN00085(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by R Preston Mason filed Critical R Preston Mason
Publication of TNSN00085A1 publication Critical patent/TNSN00085A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

L'INVENTION CONCERNE UNE COMPOSITION PHARMACEUTIQUE COMPRENANT DE L'AMLODIPINE ET DE L'ATORVASTATINE OU UN METABOLITE HYDROXYLE D'ATORVASTATINE. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION. APPLICATION : UTILISATION DE CETTE COMPOSITION, AYANT UN EFFET ANTI- OXYDANT SYNERGIQUE SUR LA PEROXYDATION DES LIPIDES, POUR LE TRAITEMENT DE MALADIES ARTERIELLES ET MALADIES CARDIAQUES APPARENTEES.
TNTNSN00085A 1999-04-23 2000-04-21 Composition pharmaceutique comprenant de l'amlodipine et de l'atorvastatine ou un de ses metabolites TNSN00085A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13066599P 1999-04-23 1999-04-23
US14530599P 1999-07-23 1999-07-23
US15112199P 1999-08-27 1999-08-27
US16659299P 1999-11-19 1999-11-19

Publications (1)

Publication Number Publication Date
TNSN00085A1 true TNSN00085A1 (fr) 2005-11-10

Family

ID=27494873

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN00085A TNSN00085A1 (fr) 1999-04-23 2000-04-21 Composition pharmaceutique comprenant de l'amlodipine et de l'atorvastatine ou un de ses metabolites

Country Status (30)

Country Link
EP (1) EP1173172B1 (fr)
JP (1) JP2002542289A (fr)
KR (1) KR20020024581A (fr)
CN (1) CN1351492A (fr)
AP (1) AP2001002324A0 (fr)
AT (1) ATE314846T1 (fr)
AU (1) AU4647000A (fr)
BG (1) BG106115A (fr)
BR (1) BR0010689A (fr)
CA (1) CA2370639A1 (fr)
CZ (1) CZ20013793A3 (fr)
DE (1) DE60025344T2 (fr)
DK (1) DK1173172T3 (fr)
EA (1) EA004435B1 (fr)
EE (1) EE200100555A (fr)
ES (1) ES2256005T3 (fr)
HK (1) HK1043741A1 (fr)
HU (1) HUP0201016A3 (fr)
IL (1) IL146085A0 (fr)
IS (1) IS6118A (fr)
NO (1) NO20015128L (fr)
OA (1) OA11870A (fr)
PE (1) PE20010055A1 (fr)
PL (1) PL351408A1 (fr)
PT (1) PT1173172E (fr)
SK (1) SK15382001A3 (fr)
SV (1) SV2002000058A (fr)
TN (1) TNSN00085A1 (fr)
UY (1) UY26118A1 (fr)
WO (1) WO2000064443A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114497A1 (en) * 2001-07-31 2003-06-19 Laman Alani Pharmaceutical compositions of amlodipine and atorvastatin
CN100430057C (zh) * 2005-04-08 2008-11-05 石药集团中奇制药技术（石家庄）有限公司 左旋氨氯地平和阿托伐他汀的药物组合物
KR101467110B1 (ko) * 2013-08-01 2014-11-28 한국방송공사 코로나링을 구비한 지선애자

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385929A (en) * 1994-05-04 1995-01-31 Warner-Lambert Company [(Hydroxyphenylamino) carbonyl] pyrroles
GT199800127A (es) * 1997-08-29 2000-02-01 Combinaciones terapeuticas.

Also Published As

Publication number Publication date
CN1351492A (zh) 2002-05-29
NO20015128D0 (no) 2001-10-19
EE200100555A (et) 2002-12-16
EA004435B1 (ru) 2004-04-29
IL146085A0 (en) 2002-07-25
ES2256005T3 (es) 2006-07-16
SK15382001A3 (sk) 2002-05-09
EP1173172A1 (fr) 2002-01-23
CA2370639A1 (fr) 2000-11-02
AU4647000A (en) 2000-11-10
OA11870A (en) 2006-03-27
PE20010055A1 (es) 2001-01-30
EA200101112A1 (ru) 2002-06-27
ATE314846T1 (de) 2006-02-15
EP1173172A4 (fr) 2002-08-07
DE60025344T2 (de) 2006-09-28
WO2000064443A1 (fr) 2000-11-02
PL351408A1 (en) 2003-04-22
NO20015128L (no) 2001-12-20
HK1043741A1 (zh) 2002-09-27
BR0010689A (pt) 2002-02-19
KR20020024581A (ko) 2002-03-30
DK1173172T3 (da) 2006-05-15
JP2002542289A (ja) 2002-12-10
IS6118A (is) 2001-10-19
HUP0201016A2 (hu) 2002-07-29
DE60025344D1 (de) 2006-03-30
UY26118A1 (es) 2001-03-16
SV2002000058A (es) 2002-02-05
WO2000064443A9 (fr) 2002-08-29
BG106115A (bg) 2002-11-29
PT1173172E (pt) 2006-05-31
CZ20013793A3 (cs) 2002-05-15
HUP0201016A3 (en) 2003-03-28
EP1173172B1 (fr) 2006-01-04
AP2001002324A0 (en) 2001-12-31

Similar Documents

Publication Publication Date Title
TNSN98017A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98182A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99053A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
TNSN01017A1 (fr) Compositions comprenant un antibiotique azalide, et procedes pour leur preparation
TNSN01053A1 (fr) Compositions nouvelles comprenant un agoniste partiel des recepteurs de nicotine et un agent analgesique
TNSN00036A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN01125A1 (fr) Compositions pharmaceutiques comprenant un inhibiteur de cetp et de l'atorvastatine
TNSN98025A1 (fr) Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant.
TNSN98238A1 (fr) Macrolides nouveaux
TNSN98155A1 (fr) Associations de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
CA2348725A1 (fr) Analogues de la vitamine d
TNSN99055A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
BE1002249A4 (fr) Compositions pharmaceutiques.
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
TNSN98156A1 (fr) Associations pharmaceutiques d'amlodipine et d'atorvastatine et procede pour leur preparation
TNSN97198A1 (fr) Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant
TNSN99133A1 (fr) Procede perfectionne pour la preparation de bases de schiff et produits ainsi obtenus
MA26608A1 (fr) Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque.
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99214A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
BR9911884A (pt) Preparação farmacêutica
EP0752249A3 (fr) Utilisation d'un antagoniste de l'angiotensine II et d'un dérivé du benzofurane à activité antiarythmique pour la préparation d'un médicament utile dans le traitement des affections cardiovasculaires